U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.880del (p.Glu294fs) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 21, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003196404.2

Allele description [Variation Report for NM_000546.6(TP53):c.880del (p.Glu294fs)]

NM_000546.6(TP53):c.880del (p.Glu294fs)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.880del (p.Glu294fs)
HGVS:
  • NC_000017.11:g.7673743del
  • NG_017013.2:g.18811del
  • NM_000546.6:c.880delMANE SELECT
  • NM_001126112.3:c.880del
  • NM_001126113.3:c.880del
  • NM_001126114.3:c.880del
  • NM_001126115.2:c.484del
  • NM_001126116.2:c.484del
  • NM_001126117.2:c.484del
  • NM_001126118.2:c.763del
  • NM_001276695.3:c.763del
  • NM_001276696.3:c.763del
  • NM_001276697.3:c.403del
  • NM_001276698.3:c.403del
  • NM_001276699.3:c.403del
  • NM_001276760.3:c.763del
  • NM_001276761.3:c.763del
  • NM_001407262.1:c.880del
  • NM_001407263.1:c.763del
  • NM_001407264.1:c.880del
  • NM_001407265.1:c.763del
  • NM_001407266.1:c.880del
  • NM_001407267.1:c.763del
  • NM_001407268.1:c.880del
  • NM_001407269.1:c.763del
  • NM_001407270.1:c.880del
  • NM_001407271.1:c.763del
  • NP_000537.3:p.Glu294Serfs
  • NP_000537.3:p.Glu294fs
  • NP_001119584.1:p.Glu294Serfs
  • NP_001119584.1:p.Glu294fs
  • NP_001119585.1:p.Glu294Serfs
  • NP_001119585.1:p.Glu294fs
  • NP_001119586.1:p.Glu294Serfs
  • NP_001119586.1:p.Glu294fs
  • NP_001119587.1:p.Glu162Serfs
  • NP_001119587.1:p.Glu162fs
  • NP_001119588.1:p.Glu162Serfs
  • NP_001119588.1:p.Glu162fs
  • NP_001119589.1:p.Glu162Serfs
  • NP_001119589.1:p.Glu162fs
  • NP_001119590.1:p.Glu255Serfs
  • NP_001119590.1:p.Glu255fs
  • NP_001263624.1:p.Glu255fs
  • NP_001263625.1:p.Glu255fs
  • NP_001263626.1:p.Glu135fs
  • NP_001263627.1:p.Glu135fs
  • NP_001263628.1:p.Glu135fs
  • NP_001263689.1:p.Glu255fs
  • NP_001263690.1:p.Glu255fs
  • NP_001394191.1:p.Glu294fs
  • NP_001394192.1:p.Glu255fs
  • NP_001394193.1:p.Glu294fs
  • NP_001394194.1:p.Glu255fs
  • NP_001394195.1:p.Glu294fs
  • NP_001394196.1:p.Glu255fs
  • NP_001394197.1:p.Glu294fs
  • NP_001394198.1:p.Glu255fs
  • NP_001394199.1:p.Glu294fs
  • NP_001394200.1:p.Glu255fs
  • LRG_321t1:c.877del
  • LRG_321t2:c.877del
  • LRG_321t3:c.877del
  • LRG_321t4:c.877del
  • LRG_321t5:c.481del
  • LRG_321t6:c.481del
  • LRG_321t7:c.481del
  • LRG_321t8:c.760del
  • LRG_321:g.18811del
  • LRG_321:p.Glu294Serfs
  • LRG_321p1:p.Glu294Serfs
  • LRG_321p3:p.Glu294Serfs
  • LRG_321p4:p.Glu294Serfs
  • LRG_321p5:p.Glu162Serfs
  • LRG_321p6:p.Glu162Serfs
  • LRG_321p7:p.Glu162Serfs
  • LRG_321p8:p.Glu255Serfs
  • NC_000017.10:g.7577058del
  • NC_000017.10:g.7577061del
  • NM_000546.4:c.880delG
  • NM_000546.5:c.877delG
  • NM_001126112.2:c.877delG
  • NM_001126113.2:c.877delG
  • NM_001126114.2:c.877delG
  • NM_001126115.1:c.481delG
  • NM_001126116.1:c.481delG
  • NM_001126117.1:c.481delG
  • NM_001126118.1:c.760delG
  • NR_176326.1:n.909del
Protein change:
E135fs
Molecular consequence:
  • NM_000546.6:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126112.3:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126113.3:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126114.3:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126115.2:c.484del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126116.2:c.484del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126117.2:c.484del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001126118.2:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276695.3:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276696.3:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276697.3:c.403del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276698.3:c.403del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276699.3:c.403del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276760.3:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001276761.3:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407262.1:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407263.1:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407264.1:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407265.1:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407266.1:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407267.1:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407268.1:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407269.1:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407270.1:c.880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407271.1:c.763del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_176326.1:n.909del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003878913Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Feb 21, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV003878913.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.880delG pathogenic mutation, located in coding exon 7 of the TP53 gene, results from a deletion of one nucleotide at nucleotide position 880, causing a translational frameshift with a predicted alternate stop codon (p.E294Sfs*51). This variant has been determined to be the result of a de novo mutation or germline mosaicism in one individual with TP53-associated disease (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024